Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

2001/03/01 by Werner Hoch, John McConville, Sigrun Helms +4 · 11 citations
Medicine · #Myasthenia Gravis and Thymoma #Peripheral Neuropathies and Disorders

paper · doi:10.1038/85520

crossref issued 2001/03/01 · crossref published 2001/03/01 · crossref published-print 2001/03/01 · openalex publication_date 2001/03/01 · crossref created 2002/07/26 · crossref deposited 2023/05/18 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31 · crossref indexed 2026/07/31

Cited by

• Treatment of Myasthenia Gravis
• Treatment of Myasthenia Gravis by Preventing Acetylcholine Receptor Modulation
• Ephedrine for myasthenia gravis, neonatal myasthenia and the congenital myasthenic syndromes
• IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†
• Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms
• Diagnosis and management of myasthenia gravis
• Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system
• Rituximab treatment of myasthenia gravis: A systematic review
• Myasthenia gravis: an update for the clinician
• Myasthenia gravis: past, present, and future
• Angela Vincent [wikipedia]